D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
KNSA holding history
Kiniksa Pharmaceuticals International, plc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KNSA overviewAll 13F holders of KNSAFull Q2 2026 holdings
- Shares (Q2 2026)
- 569,756
- Value
- $36.4M
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 569,756 | $36.4M | <0.1% | −389,501−40.6% | Reduced | Holders |
| Q1 2026 | 959,257 | $46.2M | <0.1% | −282,364−22.7% | Reduced | Holders |
| Q4 2025 | 1,241,621 | $51.2M | <0.1% | +107,435+9.5% | Added | Holders |
| Q3 2025 | 1,134,186 | $44.0M | <0.1% | +342,881+43.3% | Added | Holders |
| Q2 2025 | 791,305 | $21.9M | <0.1% | +393,560+98.9% | Added | Holders |
| Q1 2025 | 397,745 | $8.83M | <0.1% | +77,738+24.3% | Added | Holders |
| Q4 2024 | 320,007 | $6.33M | <0.1% | −990−0.3% | Reduced | Holders |
| Q3 2024 | 320,997 | $8.02M | <0.1% | +151,349+89.2% | Added | Holders |
| Q2 2024 | 169,648 | $3.17M | <0.1% | −52,205−23.5% | Reduced | Holders |
| Q1 2024 | 221,853 | $4.38M | <0.1% | −82,752−27.2% | Reduced | Holders |
| Q4 2023 | 304,605 | $5.34M | <0.1% | −12,914−4.1% | Reduced | Holders |
| Q3 2023 | 317,519 | $5.52M | <0.1% | +78,919+33.1% | Added | Holders |
| Q2 2023 | 238,600 | $3.36M | <0.1% | −1,188−0.5% | Reduced | Holders |
| Q1 2023 | 239,788 | $2.58M | <0.1% | +2,343+1.0% | Added | Holders |
| Q4 2022 | 237,445 | $3.56M | <0.1% | +125,274+111.7% | Added | Holders |
| Q3 2022 | 112,171 | $1.44M | <0.1% | +69,243+161.3% | Added | Holders |
| Q2 2022 | 42,928 | $416.0K | <0.1% | +42,928 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −12,317−100.0% | Sold out | Holders |
| Q4 2021 | 12,317 | $145.0K | <0.1% | +12,317 | New | Holders |